Herpesviridae infectious disease
Therapeutic area
Infectious Disease
Rare disease
No
- Definition
- Virus diseases caused by the herpesviridae.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Herpesviridae infectious disease
- Therapeutic area
- Infectious Disease
- Herpesviridae infectious disease
- Herpesviridae caused disease or disorder
- Herpesviridae disease or disorder
- Herpesviridae infections
- herpesvirus infection
- Herpesviridae infection
- Herpesvirus infection
- Herpesvirus infections
- infection, Herpesviridae
- infection, Herpesvirus
- infections, Herpesviridae
- infections, Herpesvirus
- Disease mechanisms
- Acquired
- All therapeutic areas
- Infectious Disease
- Severity
- Moderate
- MONDO ID
- MONDO:0005794
- Parent condition
- MONDO:0100329
Related records
Broader conditions (7)
- Disease
- Disease by etiologic mechanism
- Disease of primarily extrinsic mechanism
- Human disease
- Infectious disease
- Primary viral infectious disease
- Viral infectious disease
Narrower conditions (41)
- Chickenpox
- Congenital herpes simplex virus infection
- Congenital herpes virus infection
- Cytomegalovirus infection
- Cytomegalovirus pneumonia
- Cytomegalovirus pneumonia due to NOS2 deficiency
- Cytomegalovirus retinitis
- Endotheliitis
- Epstein-Barr virus hepatitis
- Epstein-Barr virus infection
- Fetal cytomegalovirus syndrome
- Geniculate herpes zoster
- Genital herpes
- Genital herpes simplex type 1 infectious disorder
- Genital herpes simplex type 2 infectious disorder
- Herpes labialis
- Herpes simplex dermatitis
- Herpes simplex encephalitis
- Herpes simplex infectious disease
- Herpes simplex type 1 infectious disease
Trials (28)
- A Multicenter, Double Blind, Comparative Study of Zidovudine Alone Versus Zidovudine and Acyclovir as Treatment for HIV-Infected Patients With CD4+ Counts Less Than 200 Cells/mm3
- A Phase 2 Study to Describe the Safety, Reactogenicity, and Immunogenicity of Herpes Zoster IN001 mRNA Vaccine (IN001) in Healthy Participants
- A Study to Describe the Safety, Reactogenicity, and Immunogenicity of Herpes Zoster IN001 mRNA Vaccine (IN001) in Healthy Participants
- An Open Label Study to Evaluate the Safety and Efficacy of BOR15001L7 for the Treatment of Cold Sores in Patients With Recurrent Herpes Labialis
- Assessment of Patients With Multiple Sclerosis (MS)
- Comparison of Prophylactic Acyclovir and Placebo in Prevention of Eczema Herpeticum in Pediatric Burns
- Cups or Cash for Girls Trial to Reduce Sexual and Reproductive Harm and School Dropout
- Herpesvirus in Idiopathic Pulmonary Fibrosis
- Improving Prescribing Quality for Oral Mucosal Disorders Using a Pharmacist-Led Model
- Inflammation, Infection, and Future Cardiovascular Risk
- Long-term Effectiveness of the Live Attenuated Herpes Zoster Vaccine
- Pharmacokinetics of Intravenous Acyclovir in Oncologic Paediatric Patients
- Phase I/II Study of High-Dose Acyclovir for Central Nervous System or Disseminated Neonatal Herpes Simplex Virus Infection
- Phase I/II Study of Human Anti-Cytomegalovirus (CMV) Monoclonal Antibody MSL-109 in Newborns With Symptomatic Congenital CMV Infection Without Central Nervous System Disease
- Phase III Randomized Controlled Study of Morphine and Nortriptyline in the Management of Postherpetic Neuralgia
- Phase III Randomized Study of Oral Acyclovir in Infants With Herpes Simplex Virus Infection Involving the Central Nervous System
- Phase III Randomized Study of Oral Acyclovir in Infants With Herpes Simplex Virus Infection Limited to Skin, Eyes, and Mouth
- Phase III Randomized, Controlled Study of Ganciclovir for Symptomatic Congenital Cytomegalovirus Infection
- Phase III Randomized, Placebo-Controlled Study of Acyclovir Oral Suspension for Neonatal Herpes Simplex Virus Infection Limited to the Skin, Eyes, and Mouth
- Prophylaxis With Ganciclovir Improves Graft Survival in Renal Allograft Recipients